• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SREBP1 下游的 mTORC1 对 H-ras 和 K-ras4B 的相反反馈。

Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1.

机构信息

Turku Centre for Biotechnology, Åbo Akademi University, Tykistökatu 6B, 20520, Turku, Finland.

出版信息

Sci Rep. 2017 Aug 21;7(1):8944. doi: 10.1038/s41598-017-09387-8.

DOI:10.1038/s41598-017-09387-8
PMID:28827765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5567141/
Abstract

As a major growth factor transducer, Ras is an upstream activator of mTORC1, which further integrates nutrient and energy inputs. To ensure a contextual coupling of cell division via Ras/MAPK-signalling and growth via mTORC1-signalling, feedback loops from one pathway back to the other are required. Here we describe a novel feedback from mTORC1, which oppositely affects oncogenic H-ras- and K-ras-signalling output, and as a consequence stemness properties of tumourigenic cells. Amino acid stimulation of mTORC1 increases the processed form of SREBP1, a major lipidome regulator. We show that modulation of the SREBP1 levels downstream of S6K1 has opposite effects on oncogenic H-ras and K-ras nanoscale membrane organisation, ensuing signalling output and promotion of mammospheres expressing these oncogenes. Our data suggest that modulation of phosphatidic acid, a major target of SREBP1 controlled lipid metabolism, is sufficient to affect H-ras and K-ras oppositely in the membrane. Thus mTORC1 activation increases H-ras-, but decreases K-ras-signalling output in cells transformed with the respective oncogene. Given the different impact of these two Ras isoforms on stemness, our results could have implications for stem cell biology and inhibition of cancer stem cells.

摘要

作为一种主要的生长因子转导蛋白,Ras 是 mTORC1 的上游激活剂,它进一步整合了营养和能量的输入。为了确保 Ras/MAPK 信号通路通过细胞分裂与 mTORC1 信号通路通过生长的上下文耦合,需要从一条通路反馈回另一条通路的反馈回路。在这里,我们描述了一种来自 mTORC1 的新型反馈,它对致癌的 H-ras 和 K-ras 信号输出产生相反的影响,从而影响肿瘤发生细胞的干性特性。mTORC1 对氨基酸的刺激增加了 SREBP1 的加工形式,SREBP1 是主要的脂质组调节剂。我们表明,S6K1 下游的 SREBP1 水平的调节对致癌的 H-ras 和 K-ras 纳米级膜组织具有相反的影响,从而影响信号输出并促进表达这些致癌基因的乳球体。我们的数据表明,磷酸脂酸的调节,SREBP1 控制的脂质代谢的主要靶标,足以在膜中对 H-ras 和 K-ras 产生相反的影响。因此,mTORC1 的激活增加了转化为相应致癌基因的细胞中的 H-ras-,但降低了 K-ras 信号输出。鉴于这两种 Ras 同工型对干性的不同影响,我们的结果可能对干细胞生物学和抑制癌症干细胞具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/aaab4379a3a7/41598_2017_9387_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/99a17e5c6f12/41598_2017_9387_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/fd47a94082a5/41598_2017_9387_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/469ed1e94e0b/41598_2017_9387_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/1b3de96b4224/41598_2017_9387_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/17133514e4b2/41598_2017_9387_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/64ca1add826d/41598_2017_9387_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/aaab4379a3a7/41598_2017_9387_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/99a17e5c6f12/41598_2017_9387_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/fd47a94082a5/41598_2017_9387_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/469ed1e94e0b/41598_2017_9387_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/1b3de96b4224/41598_2017_9387_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/17133514e4b2/41598_2017_9387_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/64ca1add826d/41598_2017_9387_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab6/5567141/aaab4379a3a7/41598_2017_9387_Fig7_HTML.jpg

相似文献

1
Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1.SREBP1 下游的 mTORC1 对 H-ras 和 K-ras4B 的相反反馈。
Sci Rep. 2017 Aug 21;7(1):8944. doi: 10.1038/s41598-017-09387-8.
2
Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP.致癌性PI3K和K-Ras通过mTORC1和SREBP刺激从头脂质合成。
Oncogene. 2016 Mar 10;35(10):1250-60. doi: 10.1038/onc.2015.179. Epub 2015 Jun 1.
3
Oncogenic KRAS signaling activates mTORC1 through COUP-TFII-mediated lactate production.致癌性 KRAS 信号通过 COUP-TFII 介导的乳酸生成激活 mTORC1。
EMBO Rep. 2019 Jun;20(6). doi: 10.15252/embr.201847451. Epub 2019 Apr 15.
4
mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci.mTORC1 通过 SREBP 基因座编码的 miR-33 抑制 PIM3 的表达。
Sci Rep. 2017 Nov 23;7(1):16112. doi: 10.1038/s41598-017-16398-y.
5
SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling.SPRED1干扰K-ras而非H-ras的膜锚定和信号传导。
Mol Cell Biol. 2016 Sep 26;36(20):2612-25. doi: 10.1128/MCB.00191-16. Print 2016 Oct 15.
6
Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner.雷帕霉素类似物可在体外以半乳糖凝集素-1和H-Ras依赖性方式促进癌细胞干性。
Oncotarget. 2017 Jul 4;8(27):44550-44566. doi: 10.18632/oncotarget.17819.
7
Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.mTORC1和mTORC2的离散信号传导机制:在细胞和分子层面既相互联系又彼此独立。
Adv Biol Regul. 2017 May;64:39-48. doi: 10.1016/j.jbior.2016.12.001. Epub 2017 Jan 4.
8
Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation.K-Ras效应器组织原理以及致癌性K-Ras通过G1细胞周期失调在癌症起始中的作用。
Expert Rev Proteomics. 2015;12(6):669-82. doi: 10.1586/14789450.2015.1100079. Epub 2015 Oct 23.
9
Impact of Nrf2 on tumour growth and drug sensitivity in oncogenic K-ras-transformed cells in vitro and in vivo.Nrf2 对体外和体内致癌性 K-ras 转化细胞的肿瘤生长和药物敏感性的影响。
Free Radic Res. 2018 Jun;52(6):661-671. doi: 10.1080/10715762.2018.1462494. Epub 2018 May 3.
10
Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers.表型筛选确定蛋白质合成抑制剂为增加H-Ras纳米簇的肿瘤生长诱导剂。
Biochemistry. 2015 Dec 15;54(49):7212-21. doi: 10.1021/acs.biochem.5b00724. Epub 2015 Nov 30.

引用本文的文献

1
Oscillatory ERK Signaling and Morphology Determine Heterogeneity of Breast Cancer Cell Chemotaxis via MEK-ERK and p38-MAPK Signaling Pathways.振荡性细胞外信号调节激酶信号传导与形态通过MEK-ERK和p38丝裂原活化蛋白激酶信号通路决定乳腺癌细胞趋化性的异质性。
Bioengineering (Basel). 2023 Feb 18;10(2):269. doi: 10.3390/bioengineering10020269.
2
Effects of Noonan Syndrome-Germline Mutations on Mitochondria and Energy Metabolism.努南综合征种系突变对线粒体和能量代谢的影响。
Cells. 2022 Oct 1;11(19):3099. doi: 10.3390/cells11193099.
3
Elaiophylin Is a Potent Hsp90/ Cdc37 Protein Interface Inhibitor with K-Ras Nanocluster Selectivity.

本文引用的文献

1
Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner.雷帕霉素类似物可在体外以半乳糖凝集素-1和H-Ras依赖性方式促进癌细胞干性。
Oncotarget. 2017 Jul 4;8(27):44550-44566. doi: 10.18632/oncotarget.17819.
2
Lipid-Sorting Specificity Encoded in K-Ras Membrane Anchor Regulates Signal Output.K-Ras膜锚定区编码的脂质分选特异性调节信号输出。
Cell. 2017 Jan 12;168(1-2):239-251.e16. doi: 10.1016/j.cell.2016.11.059. Epub 2016 Dec 29.
3
Hypoxia-responsive miR-210 promotes self-renewal capacity of colon tumor-initiating cells by repressing ISCU and by inducing lactate production.
埃萝啡林是一种有效的 HSP90/Cdc37 蛋白界面抑制剂,对 K-Ras 纳米簇具有选择性。
Biomolecules. 2021 Jun 4;11(6):836. doi: 10.3390/biom11060836.
4
FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage.FRET 分析 Ras 纳米簇集和膜锚定。
Methods Mol Biol. 2021;2262:233-250. doi: 10.1007/978-1-0716-1190-6_13.
5
Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling.新型小分子热休克蛋白90/细胞分裂周期蛋白37界面抑制剂间接靶向K-Ras信号通路。
Cancers (Basel). 2021 Feb 23;13(4):927. doi: 10.3390/cancers13040927.
6
Pre-existing Cell States Control Heterogeneity of Both EGFR and CXCR4 Signaling.预先存在的细胞状态控制EGFR和CXCR4信号传导的异质性。
Cell Mol Bioeng. 2020 Jul 27;14(1):49-64. doi: 10.1007/s12195-020-00640-1. eCollection 2021 Feb.
7
NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane.NRAS 在需要 ICMT 将其转运到质膜这一点上是 RAS 蛋白家族中独一无二的。
Life Sci Alliance. 2021 Feb 12;4(5). doi: 10.26508/lsa.202000972. Print 2021 May.
8
Promotion of cancer cell stemness by Ras.Ras 促进癌细胞干性。
Biochem Soc Trans. 2021 Feb 26;49(1):467-476. doi: 10.1042/BST20200964.
9
Mechanisms of Ras Membrane Organization and Signaling: Ras Rocks Again.Ras 膜组织与信号转导机制:Ras 再次引发关注。
Biomolecules. 2020 Nov 6;10(11):1522. doi: 10.3390/biom10111522.
10
PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras Activity.具有新设计原理的磷酸二酯酶6D(PDE6D)抑制剂可选择性阻断K-Ras活性。
ACS Omega. 2019 Dec 23;5(1):832-842. doi: 10.1021/acsomega.9b03639. eCollection 2020 Jan 14.
缺氧反应性miR-210通过抑制ISCU和诱导乳酸生成来促进结肠肿瘤起始细胞的自我更新能力。
Oncotarget. 2016 Oct 4;7(40):65454-65470. doi: 10.18632/oncotarget.11772.
4
The interplay between cell signalling and the mevalonate pathway in cancer.细胞信号转导与癌症中的甲羟戊酸途径的相互作用。
Nat Rev Cancer. 2016 Nov;16(11):718-731. doi: 10.1038/nrc.2016.76. Epub 2016 Aug 26.
5
SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling.SPRED1干扰K-ras而非H-ras的膜锚定和信号传导。
Mol Cell Biol. 2016 Sep 26;36(20):2612-25. doi: 10.1128/MCB.00191-16. Print 2016 Oct 15.
6
ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold.ASPP2是一种新型的泛Ras纳米簇支架蛋白。
PLoS One. 2016 Jul 20;11(7):e0159677. doi: 10.1371/journal.pone.0159677. eCollection 2016.
7
Cancer Stem Cells: Basic Concepts and Therapeutic Implications.癌症干细胞:基本概念与治疗意义。
Annu Rev Pathol. 2016 May 23;11:47-76. doi: 10.1146/annurev-pathol-012615-044438.
8
Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering.半乳糖凝集素-1二聚体可以搭建Raf效应器的支架,以增加H-ras纳米簇集。
Sci Rep. 2016 Apr 18;6:24165. doi: 10.1038/srep24165.
9
RAS isoforms and mutations in cancer at a glance.癌症中的RAS亚型与突变一览。
J Cell Sci. 2016 Apr 1;129(7):1287-92. doi: 10.1242/jcs.182873. Epub 2016 Mar 16.
10
Cancer stem cell drugs target K-ras signaling in a stemness context.癌症干细胞药物在干性环境中靶向K-ras信号通路。
Oncogene. 2016 Oct 6;35(40):5248-5262. doi: 10.1038/onc.2016.59. Epub 2016 Mar 14.